| Gayla R Ramey, APRN | |
|
16 Duke Dr, Lugoff, SC 29078-9556 | |
| (803) 295-0607 | |
| Not Available |
| Full Name | Gayla R Ramey |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 16 Duke Dr, Lugoff, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063048122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 23791 (South Carolina) | Primary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191209002986 |
News Archive
Early onset drinking, drinking and intoxication at an early age among adolescents, has been identified as a primary risk for later heavy drinking, alcohol problems, and alcohol dependence among youth and young adults. To prevent or delay early onset drinking, we must know more about the modifiable circumstances that enable these behaviors.
CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced it has initiated a Phase I study assessing the intratumoral application of its novel RNAdjuvant technology in patients with superficial solid tumors that are easily accessible for repeated intratumoral injections. RNAdjuvant is designed to amplify the scope and quality of an immune response when used alone or in combination with other immune therapies.
According to a new report from the World Health Organization (WHO) released yesterday, antibiotics development at present is not at par with the rising antimicrobial resistance worldwide and soon the demand may outgrow the supply. The WHO warns that this could mean that pathogens causing these infections could mean a great threat for humans in the coming years.
Harvest Technologies Corp. announced today that the company sponsored 48-patient IDE clinical trial conducted at seven sites in the U.S. and one site in India using the company's Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI) has completed enrollment. Mark D. Iafrati, M.D. Chief of Vascular Surgery at Tufts Medical Center in Boston, directed the study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gayla R Ramey, APRN 16 Duke Dr, Lugoff, SC 29078-9556 Ph: (803) 295-0607 | Gayla R Ramey, APRN 16 Duke Dr, Lugoff, SC 29078-9556 Ph: (803) 295-0607 |
News Archive
Early onset drinking, drinking and intoxication at an early age among adolescents, has been identified as a primary risk for later heavy drinking, alcohol problems, and alcohol dependence among youth and young adults. To prevent or delay early onset drinking, we must know more about the modifiable circumstances that enable these behaviors.
CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced it has initiated a Phase I study assessing the intratumoral application of its novel RNAdjuvant technology in patients with superficial solid tumors that are easily accessible for repeated intratumoral injections. RNAdjuvant is designed to amplify the scope and quality of an immune response when used alone or in combination with other immune therapies.
According to a new report from the World Health Organization (WHO) released yesterday, antibiotics development at present is not at par with the rising antimicrobial resistance worldwide and soon the demand may outgrow the supply. The WHO warns that this could mean that pathogens causing these infections could mean a great threat for humans in the coming years.
Harvest Technologies Corp. announced today that the company sponsored 48-patient IDE clinical trial conducted at seven sites in the U.S. and one site in India using the company's Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI) has completed enrollment. Mark D. Iafrati, M.D. Chief of Vascular Surgery at Tufts Medical Center in Boston, directed the study.
› Verified 7 days ago
Felicia Denise Harris, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15 Exchange Dr, Lugoff, SC 29078 Phone: 803-424-2200 Fax: 803-408-8608 | |
Justin M Crawford, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 710 Dewitt Dr, Lugoff, SC 29078 Phone: 803-438-1806 | |
Cathy Porter, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1165 Highway 1 S, Suite 400, Lugoff, SC 29078 Phone: 803-408-3262 Fax: 803-408-8895 | |
Jill S Sheorn, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 116 Standard Warehouse Rd, Lugoff, SC 29078 Phone: 803-438-6023 Fax: 803-438-3671 | |
Ayzia Taylor, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 40 Baldwin Ave, Lugoff, SC 29078 Phone: 803-408-3262 | |
Anne B Blake, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 710 Dewitt Dr, Lugoff, SC 29078 Phone: 803-438-7566 Fax: 803-438-4371 |